A. H. Loonen - Concepedia

Author

A. H. Loonen

Stichting Kinderoncologie Nederland

Also Known As

A H Loonen, A. H. Loonen, A.H. Loonen, AH Loonen, Anne H. Loonen, Anne Loonen

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Stichting Kinderoncologie Nederland Erasmus MC - Sophia Children’s Hospital Amsterdam UMC Location Vrije Universiteit Amsterdam University of Amsterdam Erasmus University Rotterdam

About

A. H. Loonen is an author at Stichting Kinderoncologie Nederland specializing in medicine, hematology, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	914
2	Health Sciences	4	4	374
3	Natural Sciences	1	1	89
4	Public Health	1	1	47
5	Allergy	1	1	47

A. H. Loonen

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia Bianca F. Goemans, Ch. M. Zwaan, Mitchell Miller, Leukemia Hematological MalignancyChromatinPediatric HematologyMedicineGenetics	2005	239
Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia Rob Pieters, D. R. Huismans, A. H. Loonen, The Lancet Hematological MalignancyHealth SciencesPediatric HematologyMedicineMixed-phenotype Acute Leukemia	1991	223
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. N. L. Ramakers-Van Woerden, R. Pieters, A. H. Loonen, PubMed	2000	151
A Genome-Wide View of the <i>In vitro</i> Response to <scp>l</scp>-Asparaginase in Acute Lymphoblastic Leukemia Bernard M. Fine, Gertjan J.L. Kaspers, Minh Ho, Cancer Research ChromatinSystems BiologyFunctional GenomicsMixed-phenotype Acute LeukemiaGenetics	2005	102
In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype N. L. Ramakers-Van Woerden, H. Berna Beverloo, A. Veerman, Leukemia Hematological MalignancyHealth SciencesMedicineMalignant Blood DisorderMixed-phenotype Acute Leukemia	2004	89
An Extracellular Signal-Regulated Kinase 1- and 2-Dependent Program of Chromatin Trafficking of c-Fos and Fra-1 Is Required for Cyclin D1 Expression during Cell Cycle Reentry Peter M. Burch, Ziqiang Yuan, A. H. Loonen, Molecular and Cellular Biology Molecular BiologyCell CycleOxidative StressSignaling PathwayCell Regulation	2004	89
A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin Willemijn van den Ancker, Theresia M. Westers, David C. de Leeuw, Cytometry Part B Clinical Cytometry	2013	48
Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome W A G Stams, H. Berna Beverloo, Monique L. den Boer, Leukemia AllergyDrug SensitivityPediatric EpidemiologyPediatric HematologyGenetic Disorder	2006	47
Hypoxanthine‐guanine phosphoribosyl‐transferase in childhood leukemia: Relation with immunophenotype, <i>in vitro</i> drug resistance and clinical prognosis Rob Pieters, D. R. Huismans, A. H. Loonen, International Journal of Cancer	1992	42
Relation of 5′-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia Rob Pieters, D. R. Huismans, A. H. Loonen, Leukemia Research Hematological MalignancyHealth SciencesPediatric HematologyChildhood LeukemiaHematology	1992	41

Page 1